
MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

Fixed-dose combination provides another oral treatment option for patients with diabetes.

Qtern is indicated to lower blood glucose levels in patients with type 2 diabetes.

The FDA has approved AstraZeneca’s fixed-dose combination drug, Qtern (10 mg dapagliflozin and 5 mg saxagliptin), for the treatment of type 2 diabetes as an adjunct to diet and exercise.

Long-term sitting may not impact diabetes risk as much as previously believed.

More than half of adults with type 2 diabetes are unaware they are at an increased risk of heart disease.

Top news of the day from across the health care landscape.

The use of MTM is expanding in the world of pharmacy. This article gives you a quick idea on what to screen for and address when analyzing a diabetic patients medication profile.

The American Diabetes Association (ADA) released their first position statement in 15 years regarding diabetic retinopathy.

Abdominal adiposity seen to increase the risk of type 2 diabetes, coronary heart disease, and cardiovascular risk factors.

Cost, forgetfulness, and complicated medication regimens drive poor patient antidiabetic medication adherence.

PCSK9 variants that lower cholesterol found to increase the risk of type 2 diabetes.

Few studies have examined the importance of socioeconomic risk factors on overall health.

Synjardy has received FDA approval for an expanded indication to include treatment-naïve adults with type 2 diabetes

The characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.

Diabetes-related deaths account for up to 12% of overall deaths.

The American Diabetes Association releases an update position statement reflecting the current diabetic neuropathy landscape.

Inhibiting theIPK61 protein was observed to stop weight gain in animals.

Researchers worked to develop a new statement for the prevention, management, and treatment of diabetic neuropathy.

Diabetes may develop or worsen with early-stage pancreatic cancer.

Onset or rapid deterioration of diabetes may be an indicator of hidden pancreatic cancer.

Label now includes the use of dulaglutide in combination with basal insulin in adults with type 2 diabetes.

Association found between medically appropriate food support and improved HIV and diabetes health.

Comprehensive nutrition could improve the overall health of patients with chronic diseases.

Health initiatives should aim to prevent weight gain in order to avert new cases of diabetes.